dantrolene has been researched along with Atherosclerotic Parkinsonism in 2 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez, EA | 1 |
Truong, DD | 1 |
Sczesni, B | 1 |
Fahn, S | 1 |
Gross, J | 1 |
Donovan, K | 1 |
van Bakel, A | 1 |
Wiley, MK | 1 |
2 other studies available for dantrolene and Atherosclerotic Parkinsonism
Article | Year |
---|---|
[Extrapyramidal reactions and neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malign | 1984 |
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neur | 1988 |